Therefore, increased Bcl-2 expression in MCF-7 cells but reduced Bcl-2 expression in MDA-MB-231 cells by heteronemin may reflect different mechanisms in different types of breast cancer cells. The gene discussed is BCL2; the disease is breast cancer.